Results 91 to 100 of about 10,639 (217)

Markers of acute rejection and graft acceptance in liver transplantation. [PDF]

open access: yes, 2015
The evaluation of the immunosuppression state in liver transplanted patients is crucial for a correct post-transplant management and a major step towards the personalisation of the immunosuppressive therapy.
Burra, Patrizia   +6 more
core   +1 more source

Expression of sIL-2R before and after chemotherapy in patients with breast cancer

open access: yesChinese Journal of Cancer Research, 2008
To investigate the difference of peripheral blood sIL-2R before and after chemotherapy in breast cancer patients, and evaluate the clinical value of the sIL-2R in breast cancer’s diagnosis and therapy. The peripheral blood sIL-2R levels of the breast cancer patients with or without chemotherapy were detected by ELISA.
Yuan-ming Fan, Zhi-jun Sun
openaire   +1 more source

Diagnostic value of soluble Interleukin-2 receptor in patients suffering neurosarcoidosis: A systematic review

open access: yesJournal of Central Nervous System Disease
Background Neurosarcoidosis is an inflammatory granulomatous disease. Up to 25% of occult sarcoidosis affecting the nervous system are only detected by autopsy. In addition, in recent years the suspicion arose that the soluble Interleukin-2 Receptor (sIL-
Aditya Chanpura   +3 more
doaj   +1 more source

Serum level of soluble interleukin‐2 receptor is positively correlated with metabolic tumor volume on 18F‐FDG PET/CT in newly diagnosed patients with diffuse large B‐cell lymphoma

open access: yesCancer Medicine, 2019
Diffuse large B‐cell lymphoma (DLBCL) is the most frequent subtype of non‐Hodgkin lymphoma. High total metabolic tumor volume (TMTV) calculated using 18F‐FDG PET/CT images at diagnosis predicts poor prognosis of patients with DLBCL.
Hajime Senjo   +15 more
doaj   +1 more source

Chronic Effects of Subcutaneous Interleukin-2 Therapy on Soluble Interleukin-2 Receptors in Advanced Small Cell Lung Cancer

open access: yesThe International Journal of Biological Markers, 1993
The increase in IL-2 receptor serum levels is one of the most typical changes in immune parameters during IL-2 cancer immunotherapy. To better define the effects of prolonged IL-2 injection on SIL-2R levels, we evaluated 7 advanced small cell lung cancer
S. Viviani   +7 more
doaj   +1 more source

YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity

open access: yesBiomolecules, 2018
The aims of this study were to describe the clinical, radiological and immunological features of a population of sarcoidosis patients and to analyse chitinase-3-like protein 1 (YKL-40), soluble interleukin-2 receptor (sIL-2R), neopterin concentrations ...
Pelin Uysal   +7 more
doaj   +1 more source

Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy

open access: yesBMC Cancer, 2017
Background Renal cell carcinoma (RCC) is a tumor with immunogenic properties. Soluble interleukin-2 receptor (sIL-2R) has a role in T cell activation and may be important for immune regulation in various conditions, including infections, transplantation ...
Akinori Nukui   +5 more
doaj   +1 more source

Evidence for gliadin antibodies as causative agents in schizophrenia. [PDF]

open access: yes, 2010
Antibodies to gliadin, a component of gluten, have frequently been reported in schizophrenia. Highly immunogenic B cell epitopes along its length are homologous to numerous proteins relevant to schizophrenia, including members of the DISC1 interactome ...
Chris J. Carter
core   +2 more sources

Home - About - Disclaimer - Privacy